Evidence map›Paper›PMID 40842984›Full record

ArticleFrontiers in immunology2025

Jing Zhu, Chun Yu, Xin Xu, Chu Zou, Jiaqi Li, Rui Wang, Xinchao Li, Aijun Sun, Shiyan Wang, Chao Jiang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jing ZhuDepartment of Oncology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an, China.
Chun YuGeneral Surgery Department, Lianshui People's Hospital Affiliated to Kangda College of Nanjing Medical University, Huai'an, Jiangsu, China.
Xin XuDepartment of Thyroid and Breast Oncological Surgery,Huai'an Second People's Hospital, TheAffiliated Huaian Hospital of Xuzhou Medical University, Huai'an, Jiangsu, China.
Chu ZouFaculty of Life Science and Food Engineering, Huaiyin Institute of Technology, Huaian, Jiangsu, China.
Jiaqi LiFaculty of Life Science and Food Engineering, Huaiyin Institute of Technology, Huaian, Jiangsu, China.
Rui WangFaculty of Life Science and Food Engineering, Huaiyin Institute of Technology, Huaian, Jiangsu, China.
Xinchao LiFaculty of Life Science and Food Engineering, Huaiyin Institute of Technology, Huaian, Jiangsu, China.
Aijun SunDepartment of Thyroid and Breast Oncological Surgery,Huai'an Second People's Hospital, TheAffiliated Huaian Hospital of Xuzhou Medical University, Huai'an, Jiangsu, China.
Shiyan WangFaculty of Life Science and Food Engineering, Huaiyin Institute of Technology, Huaian, Jiangsu, China.
Chao JiangDepartment of Oncology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The Methods: A comparative analysis of Results: Conclusion: Our study revealed the key role of

Indexed as

CarcinogenesisNeoplasmsrab5 GTP-Binding ProteinsBiomarkers, TumorGene Expression Regulation, NeoplasticHumansPrognosisTumor MicroenvironmentBiomarkers, TumorRAB5C protein, humanrab5 GTP-Binding Proteinsdrug sensitivity of immunotherapypan-cancerprognosisRAB5Btumor immunity

Identifiers

PMID40842984
PMCPMC12364618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.